The global market for Topical Drugs CDMO was valued at US$ 4800 million in the year 2024 and is projected to reach a revised size of US$ 8266 million by 2031, growing at a CAGR of 8.1% during the forecast period.

Topical Drugs CDMO Market

A Topical Drugs CDMO (Contract Development and Manufacturing Organization) is a specialized company that provides end-to-end services for the development, formulation, manufacturing, and packaging of topical drugs on behalf of pharmaceutical companies. Topical drugs are medications applied directly to the skin, mucous membranes, or other external surfaces (e.g., creams, gels, ointments, lotions, patches, sprays, and foams). These drugs are used to treat a wide range of conditions, including skin disorders, infections, pain, and inflammation.

North American market for Topical Drugs CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Topical Drugs CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Topical Drugs CDMO in Liquid Formulations is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Topical Drugs CDMO include Cambrex Corporation, Bora Pharmaceutical CDMO, Piramal Pharma Solutions, Contract Pharmaceuticals Limited, Lubrizol Life Science, Ascendia Pharmaceuticals, PCI Pharma Services, Pierre Fabre Group, DPT Laboratories LTD., MedPharm Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Topical Drugs CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Topical Drugs CDMO.

The Topical Drugs CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Topical Drugs CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Topical Drugs CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Topical Drugs CDMO Market Report

Report Metric	Details
Report Name	Topical Drugs CDMO Market
Accounted market size in year	US$ 4800 million
Forecasted market size in 2031	US$ 8266 million
CAGR	8.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Contract Development Contract Manufacturing
Segment by Application	Liquid Formulations Semi-Solid Formulations Solid Formulations Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Cambrex Corporation, Bora Pharmaceutical CDMO, Piramal Pharma Solutions, Contract Pharmaceuticals Limited, Lubrizol Life Science, Ascendia Pharmaceuticals, PCI Pharma Services, Pierre Fabre Group, DPT Laboratories LTD., MedPharm Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Topical Drugs CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Topical Drugs CDMO Market growing?

Ans: The Topical Drugs CDMO Market witnessing a CAGR of 8.1% during the forecast period 2025-2031.

What is the Topical Drugs CDMO Market size in 2031?

Ans: The Topical Drugs CDMO Market size in 2031 will be US$ 8266 million.

Who are the main players in the Topical Drugs CDMO Market report?

Ans: The main players in the Topical Drugs CDMO Market are Cambrex Corporation, Bora Pharmaceutical CDMO, Piramal Pharma Solutions, Contract Pharmaceuticals Limited, Lubrizol Life Science, Ascendia Pharmaceuticals, PCI Pharma Services, Pierre Fabre Group, DPT Laboratories LTD., MedPharm Ltd.

What are the Application segmentation covered in the Topical Drugs CDMO Market report?

Ans: The Applications covered in the Topical Drugs CDMO Market report are Liquid Formulations, Semi-Solid Formulations, Solid Formulations, Others

What are the Type segmentation covered in the Topical Drugs CDMO Market report?

Ans: The Types covered in the Topical Drugs CDMO Market report are Contract Development, Contract Manufacturing

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Topical Drugs CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Contract Development

1.2.3 Contract Manufacturing

1.3 Market by Application

1.3.1 Global Topical Drugs CDMO Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Liquid Formulations

1.3.3 Semi-Solid Formulations

1.3.4 Solid Formulations

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Topical Drugs CDMO Market Perspective (2020-2031)

2.2 Global Topical Drugs CDMO Growth Trends by Region

2.2.1 Global Topical Drugs CDMO Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Topical Drugs CDMO Historic Market Size by Region (2020-2025)

2.2.3 Topical Drugs CDMO Forecasted Market Size by Region (2026-2031)

2.3 Topical Drugs CDMO Market Dynamics

2.3.1 Topical Drugs CDMO Industry Trends

2.3.2 Topical Drugs CDMO Market Drivers

2.3.3 Topical Drugs CDMO Market Challenges

2.3.4 Topical Drugs CDMO Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Topical Drugs CDMO Players by Revenue

3.1.1 Global Top Topical Drugs CDMO Players by Revenue (2020-2025)

3.1.2 Global Topical Drugs CDMO Revenue Market Share by Players (2020-2025)

3.2 Global Top Topical Drugs CDMO Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Topical Drugs CDMO Revenue

3.4 Global Topical Drugs CDMO Market Concentration Ratio

3.4.1 Global Topical Drugs CDMO Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Topical Drugs CDMO Revenue in 2024

3.5 Global Key Players of Topical Drugs CDMO Head office and Area Served

3.6 Global Key Players of Topical Drugs CDMO, Product and Application

3.7 Global Key Players of Topical Drugs CDMO, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Topical Drugs CDMO Breakdown Data by Type

4.1 Global Topical Drugs CDMO Historic Market Size by Type (2020-2025)

4.2 Global Topical Drugs CDMO Forecasted Market Size by Type (2026-2031)

5 Topical Drugs CDMO Breakdown Data by Application

5.1 Global Topical Drugs CDMO Historic Market Size by Application (2020-2025)

5.2 Global Topical Drugs CDMO Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Topical Drugs CDMO Market Size (2020-2031)

6.2 North America Topical Drugs CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Topical Drugs CDMO Market Size by Country (2020-2025)

6.4 North America Topical Drugs CDMO Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Topical Drugs CDMO Market Size (2020-2031)

7.2 Europe Topical Drugs CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Topical Drugs CDMO Market Size by Country (2020-2025)

7.4 Europe Topical Drugs CDMO Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Topical Drugs CDMO Market Size (2020-2031)

8.2 Asia-Pacific Topical Drugs CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Topical Drugs CDMO Market Size by Region (2020-2025)

8.4 Asia-Pacific Topical Drugs CDMO Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Topical Drugs CDMO Market Size (2020-2031)

9.2 Latin America Topical Drugs CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Topical Drugs CDMO Market Size by Country (2020-2025)

9.4 Latin America Topical Drugs CDMO Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Topical Drugs CDMO Market Size (2020-2031)

10.2 Middle East & Africa Topical Drugs CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Topical Drugs CDMO Market Size by Country (2020-2025)

10.4 Middle East & Africa Topical Drugs CDMO Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Cambrex Corporation

11.1.1 Cambrex Corporation Company Details

11.1.2 Cambrex Corporation Business Overview

11.1.3 Cambrex Corporation Topical Drugs CDMO Introduction

11.1.4 Cambrex Corporation Revenue in Topical Drugs CDMO Business (2020-2025)

11.1.5 Cambrex Corporation Recent Development

11.2 Bora Pharmaceutical CDMO

11.2.1 Bora Pharmaceutical CDMO Company Details

11.2.2 Bora Pharmaceutical CDMO Business Overview

11.2.3 Bora Pharmaceutical CDMO Topical Drugs CDMO Introduction

11.2.4 Bora Pharmaceutical CDMO Revenue in Topical Drugs CDMO Business (2020-2025)

11.2.5 Bora Pharmaceutical CDMO Recent Development

11.3 Piramal Pharma Solutions

11.3.1 Piramal Pharma Solutions Company Details

11.3.2 Piramal Pharma Solutions Business Overview

11.3.3 Piramal Pharma Solutions Topical Drugs CDMO Introduction

11.3.4 Piramal Pharma Solutions Revenue in Topical Drugs CDMO Business (2020-2025)

11.3.5 Piramal Pharma Solutions Recent Development

11.4 Contract Pharmaceuticals Limited

11.4.1 Contract Pharmaceuticals Limited Company Details

11.4.2 Contract Pharmaceuticals Limited Business Overview

11.4.3 Contract Pharmaceuticals Limited Topical Drugs CDMO Introduction

11.4.4 Contract Pharmaceuticals Limited Revenue in Topical Drugs CDMO Business (2020-2025)

11.4.5 Contract Pharmaceuticals Limited Recent Development

11.5 Lubrizol Life Science

11.5.1 Lubrizol Life Science Company Details

11.5.2 Lubrizol Life Science Business Overview

11.5.3 Lubrizol Life Science Topical Drugs CDMO Introduction

11.5.4 Lubrizol Life Science Revenue in Topical Drugs CDMO Business (2020-2025)

11.5.5 Lubrizol Life Science Recent Development

11.6 Ascendia Pharmaceuticals

11.6.1 Ascendia Pharmaceuticals Company Details

11.6.2 Ascendia Pharmaceuticals Business Overview

11.6.3 Ascendia Pharmaceuticals Topical Drugs CDMO Introduction

11.6.4 Ascendia Pharmaceuticals Revenue in Topical Drugs CDMO Business (2020-2025)

11.6.5 Ascendia Pharmaceuticals Recent Development

11.7 PCI Pharma Services

11.7.1 PCI Pharma Services Company Details

11.7.2 PCI Pharma Services Business Overview

11.7.3 PCI Pharma Services Topical Drugs CDMO Introduction

11.7.4 PCI Pharma Services Revenue in Topical Drugs CDMO Business (2020-2025)

11.7.5 PCI Pharma Services Recent Development

11.8 Pierre Fabre Group

11.8.1 Pierre Fabre Group Company Details

11.8.2 Pierre Fabre Group Business Overview

11.8.3 Pierre Fabre Group Topical Drugs CDMO Introduction

11.8.4 Pierre Fabre Group Revenue in Topical Drugs CDMO Business (2020-2025)

11.8.5 Pierre Fabre Group Recent Development

11.9 DPT Laboratories LTD.

11.9.1 DPT Laboratories LTD. Company Details

11.9.2 DPT Laboratories LTD. Business Overview

11.9.3 DPT Laboratories LTD. Topical Drugs CDMO Introduction

11.9.4 DPT Laboratories LTD. Revenue in Topical Drugs CDMO Business (2020-2025)

11.9.5 DPT Laboratories LTD. Recent Development

11.10 MedPharm Ltd.

11.10.1 MedPharm Ltd. Company Details

11.10.2 MedPharm Ltd. Business Overview

11.10.3 MedPharm Ltd. Topical Drugs CDMO Introduction

11.10.4 MedPharm Ltd. Revenue in Topical Drugs CDMO Business (2020-2025)

11.10.5 MedPharm Ltd. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Company

Cambrex Corporation

Piramal Pharma Solutions

Lubrizol Life Science

Ascendia Pharmaceuticals

PCI Pharma Services

Pierre Fabre Group

MedPharm Ltd.

Bora Pharmaceutical CDMO

Contract Pharmaceuticals Limited

DPT Laboratories LTD.

List of Tables

Table 1. Global Topical Drugs CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Contract Development

Table 3. Key Players of Contract Manufacturing

Table 4. Global Topical Drugs CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Topical Drugs CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Topical Drugs CDMO Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Topical Drugs CDMO Market Share by Region (2020-2025)

Table 8. Global Topical Drugs CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Topical Drugs CDMO Market Share by Region (2026-2031)

Table 10. Topical Drugs CDMO Market Trends

Table 11. Topical Drugs CDMO Market Drivers

Table 12. Topical Drugs CDMO Market Challenges

Table 13. Topical Drugs CDMO Market Restraints

Table 14. Global Topical Drugs CDMO Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Topical Drugs CDMO Market Share by Players (2020-2025)

Table 16. Global Top Topical Drugs CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Topical Drugs CDMO as of 2024)

Table 17. Ranking of Global Top Topical Drugs CDMO Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Topical Drugs CDMO Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Topical Drugs CDMO, Headquarters and Area Served

Table 20. Global Key Players of Topical Drugs CDMO, Product and Application

Table 21. Global Key Players of Topical Drugs CDMO, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Topical Drugs CDMO Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Topical Drugs CDMO Revenue Market Share by Type (2020-2025)

Table 25. Global Topical Drugs CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Topical Drugs CDMO Revenue Market Share by Type (2026-2031)

Table 27. Global Topical Drugs CDMO Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Topical Drugs CDMO Revenue Market Share by Application (2020-2025)

Table 29. Global Topical Drugs CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Topical Drugs CDMO Revenue Market Share by Application (2026-2031)

Table 31. North America Topical Drugs CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Topical Drugs CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Topical Drugs CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Topical Drugs CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Topical Drugs CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Topical Drugs CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Topical Drugs CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Topical Drugs CDMO Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Topical Drugs CDMO Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Topical Drugs CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Topical Drugs CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Topical Drugs CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Topical Drugs CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Topical Drugs CDMO Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Topical Drugs CDMO Market Size by Country (2026-2031) & (US$ Million)

Table 46. Cambrex Corporation Company Details

Table 47. Cambrex Corporation Business Overview

Table 48. Cambrex Corporation Topical Drugs CDMO Product

Table 49. Cambrex Corporation Revenue in Topical Drugs CDMO Business (2020-2025) & (US$ Million)

Table 50. Cambrex Corporation Recent Development

Table 51. Bora Pharmaceutical CDMO Company Details

Table 52. Bora Pharmaceutical CDMO Business Overview

Table 53. Bora Pharmaceutical CDMO Topical Drugs CDMO Product

Table 54. Bora Pharmaceutical CDMO Revenue in Topical Drugs CDMO Business (2020-2025) & (US$ Million)

Table 55. Bora Pharmaceutical CDMO Recent Development

Table 56. Piramal Pharma Solutions Company Details

Table 57. Piramal Pharma Solutions Business Overview

Table 58. Piramal Pharma Solutions Topical Drugs CDMO Product

Table 59. Piramal Pharma Solutions Revenue in Topical Drugs CDMO Business (2020-2025) & (US$ Million)

Table 60. Piramal Pharma Solutions Recent Development

Table 61. Contract Pharmaceuticals Limited Company Details

Table 62. Contract Pharmaceuticals Limited Business Overview

Table 63. Contract Pharmaceuticals Limited Topical Drugs CDMO Product

Table 64. Contract Pharmaceuticals Limited Revenue in Topical Drugs CDMO Business (2020-2025) & (US$ Million)

Table 65. Contract Pharmaceuticals Limited Recent Development

Table 66. Lubrizol Life Science Company Details

Table 67. Lubrizol Life Science Business Overview

Table 68. Lubrizol Life Science Topical Drugs CDMO Product

Table 69. Lubrizol Life Science Revenue in Topical Drugs CDMO Business (2020-2025) & (US$ Million)

Table 70. Lubrizol Life Science Recent Development

Table 71. Ascendia Pharmaceuticals Company Details

Table 72. Ascendia Pharmaceuticals Business Overview

Table 73. Ascendia Pharmaceuticals Topical Drugs CDMO Product

Table 74. Ascendia Pharmaceuticals Revenue in Topical Drugs CDMO Business (2020-2025) & (US$ Million)

Table 75. Ascendia Pharmaceuticals Recent Development

Table 76. PCI Pharma Services Company Details

Table 77. PCI Pharma Services Business Overview

Table 78. PCI Pharma Services Topical Drugs CDMO Product

Table 79. PCI Pharma Services Revenue in Topical Drugs CDMO Business (2020-2025) & (US$ Million)

Table 80. PCI Pharma Services Recent Development

Table 81. Pierre Fabre Group Company Details

Table 82. Pierre Fabre Group Business Overview

Table 83. Pierre Fabre Group Topical Drugs CDMO Product

Table 84. Pierre Fabre Group Revenue in Topical Drugs CDMO Business (2020-2025) & (US$ Million)

Table 85. Pierre Fabre Group Recent Development

Table 86. DPT Laboratories LTD. Company Details

Table 87. DPT Laboratories LTD. Business Overview

Table 88. DPT Laboratories LTD. Topical Drugs CDMO Product

Table 89. DPT Laboratories LTD. Revenue in Topical Drugs CDMO Business (2020-2025) & (US$ Million)

Table 90. DPT Laboratories LTD. Recent Development

Table 91. MedPharm Ltd. Company Details

Table 92. MedPharm Ltd. Business Overview

Table 93. MedPharm Ltd. Topical Drugs CDMO Product

Table 94. MedPharm Ltd. Revenue in Topical Drugs CDMO Business (2020-2025) & (US$ Million)

Table 95. MedPharm Ltd. Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Topical Drugs CDMO Picture

Figure 2. Global Topical Drugs CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Topical Drugs CDMO Market Share by Type: 2024 VS 2031

Figure 4. Contract Development Features

Figure 5. Contract Manufacturing Features

Figure 6. Global Topical Drugs CDMO Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Topical Drugs CDMO Market Share by Application: 2024 VS 2031

Figure 8. Liquid Formulations Case Studies

Figure 9. Semi-Solid Formulations Case Studies

Figure 10. Solid Formulations Case Studies

Figure 11. Others Case Studies

Figure 12. Topical Drugs CDMO Report Years Considered

Figure 13. Global Topical Drugs CDMO Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Topical Drugs CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Topical Drugs CDMO Market Share by Region: 2024 VS 2031

Figure 16. Global Topical Drugs CDMO Market Share by Players in 2024

Figure 17. Global Topical Drugs CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Topical Drugs CDMO Revenue in 2024

Figure 19. North America Topical Drugs CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Topical Drugs CDMO Market Share by Country (2020-2031)

Figure 21. United States Topical Drugs CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Topical Drugs CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Topical Drugs CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Topical Drugs CDMO Market Share by Country (2020-2031)

Figure 25. Germany Topical Drugs CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Topical Drugs CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Topical Drugs CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Topical Drugs CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Topical Drugs CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Topical Drugs CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Topical Drugs CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Topical Drugs CDMO Market Share by Region (2020-2031)

Figure 33. China Topical Drugs CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Topical Drugs CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Topical Drugs CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Topical Drugs CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Topical Drugs CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Topical Drugs CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Topical Drugs CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Topical Drugs CDMO Market Share by Country (2020-2031)

Figure 41. Mexico Topical Drugs CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Topical Drugs CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Topical Drugs CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Topical Drugs CDMO Market Share by Country (2020-2031)

Figure 45. Turkey Topical Drugs CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Topical Drugs CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Topical Drugs CDMO Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Cambrex Corporation Revenue Growth Rate in Topical Drugs CDMO Business (2020-2025)

Figure 49. Bora Pharmaceutical CDMO Revenue Growth Rate in Topical Drugs CDMO Business (2020-2025)

Figure 50. Piramal Pharma Solutions Revenue Growth Rate in Topical Drugs CDMO Business (2020-2025)

Figure 51. Contract Pharmaceuticals Limited Revenue Growth Rate in Topical Drugs CDMO Business (2020-2025)

Figure 52. Lubrizol Life Science Revenue Growth Rate in Topical Drugs CDMO Business (2020-2025)

Figure 53. Ascendia Pharmaceuticals Revenue Growth Rate in Topical Drugs CDMO Business (2020-2025)

Figure 54. PCI Pharma Services Revenue Growth Rate in Topical Drugs CDMO Business (2020-2025)

Figure 55. Pierre Fabre Group Revenue Growth Rate in Topical Drugs CDMO Business (2020-2025)

Figure 56. DPT Laboratories LTD. Revenue Growth Rate in Topical Drugs CDMO Business (2020-2025)

Figure 57. MedPharm Ltd. Revenue Growth Rate in Topical Drugs CDMO Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Topical Drugs CDMO Market Research Report 2025

Published Date: February 2025

Report Code: QYRE-Auto-9B19140

Global Topical Drugs CDMO Market Research Report 2025

FEATURED COMPANIES

Topical Drugs CDMO Market Size

Topical Drugs CDMO Market

Scope of Topical Drugs CDMO Market Report

Chapter Outline

FAQ for this report

How fast is Topical Drugs CDMO Market growing?

What is the Topical Drugs CDMO Market size in 2031?

Who are the main players in the Topical Drugs CDMO Market report?

What are the Application segmentation covered in the Topical Drugs CDMO Market report?

What are the Type segmentation covered in the Topical Drugs CDMO Market report?

FEATURED COMPANIES

Global Beauty Devices Market Size Manufacturers Supply Chain Sales Channel and Clients 2022 2028

Single User, Electronic (PDF)